A randomised trial of radical radiotherapy with or without low dose gemcitabine in medically inoperable patients with T1-2 N0-1 M0 non-small cell lung cancer (NSCLC)

被引:0
|
作者
Price, Allan [1 ]
Yellowlees, Ann [2 ]
Faivre-Finn, Corinne [3 ]
Gilligan, David [4 ]
Snee, Michael [5 ]
Erridge, Sara [1 ]
Mohammed, Nazia [6 ]
Russell, Susan [7 ]
机构
[1] Edinburgh Canc Ctr, Edinburgh, Midlothian, Scotland
[2] QUANTICS, Melrose, Scotland
[3] Christie Hosp, Manchester, Lancs, England
[4] Addenbrookes Hosp, Cambridge, England
[5] Yorkshire Canc Ctr, Leeds, W Yorkshire, England
[6] Western Infirm & Associated Hosp, Beatson Oncol Ctr, Glasgow G11 6NT, Lanark, Scotland
[7] CACTUS, Edinburgh, Midlothian, Scotland
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S587 / S587
页数:1
相关论文
共 50 条
  • [1] Stereotactic hypofractionated radiotherapy in stage I (T1-2 N0 M0) non-small-cell lung cancer (NSCLC)
    Zimmermann, Frank B.
    Geinitz, Hans
    Schill, Sabine
    Thamm, Reinhard
    Nieder, Carsten
    Schratzenstaller, Ulrich
    Molls, Michael
    ACTA ONCOLOGICA, 2006, 45 (07) : 796 - 801
  • [2] Impact of multicentricity on clinical outcome in patients with T1-2, N0-1, M0 breast cancer
    Georges Vlastos
    Isabel T. Rubio
    Nadeem Q. Mirza
    Lisa A. Newman
    Ravi Aurora
    Julie Alderfer
    Aman U. Buzdar
    S. Eva Singletary
    Annals of Surgical Oncology, 2000, 7 : 581 - 587
  • [3] Impact of multicentricity on clinical outcome in patients with T1-2, N0-1, M0 breast cancer
    Vlastos, G
    Rubio, IT
    Mirza, NQ
    Newman, LA
    Aurora, R
    Alderfer, J
    Buzdar, AU
    Singletary, SE
    ANNALS OF SURGICAL ONCOLOGY, 2000, 7 (08) : 581 - 587
  • [4] Radical radiotherapy with or without gemcitabine in patients with early stage medically inoperable non-small cell lung cancer
    Price, Allan
    Yellowlees, Ann
    Keerie, Catriona
    Russell, Susan
    Faivre-Finn, Corinne
    Gilligan, David
    Snee, Michael
    Skailes, Geraldine
    Hatton, Matthew
    Erridge, Sara
    Mohammed, Nazia
    LUNG CANCER, 2012, 77 (03) : 532 - 536
  • [5] A randomised controlled trial of pre-operative chemotherapy followed, if feasible, by resection versus radiotherapy in patients with inoperable stage T3, N1, M0 or T1-3, N2, M0 non-small cell lung cancer
    Stephens, RJ
    Girling, DJ
    Hopwood, P
    Thatcher, N
    LUNG CANCER, 2005, 49 (03) : 395 - 400
  • [6] Improving outcomes for radical radiotherapy in T1-2 NO-1 medically inoperable non-small cell lung cancer (NSCLC); Northern Ireland experience 2001-2004
    McAleese, J.
    Ray, S.
    Eakin, R.
    Stewart, D.
    Houghton, F.
    Hanna, G.
    Carser, J.
    Stranex, S.
    LUNG CANCER, 2007, 57 : S9 - S9
  • [7] Hypofractionated 3D radiotherapy for inoperable T1-3 N0-1 non-small-cell lung cancer
    Molla Armada, Meritxell
    Saez, Jordi
    Ramos, Monica
    Giraldo, Alexandra
    Seoane, Alejandro
    Andreu, Jordi
    Simo, Marc
    Giralt, Jordi
    BRITISH JOURNAL OF RADIOLOGY, 2016, 89 (1062):
  • [8] Stereotactic ablative radiotherapy for inoperable T1-2N0M0 small-cell lung cancer
    Tang, Hui
    Liu, Wei
    Huang, Kaiming
    THORACIC CANCER, 2022, 13 (07) : 1100 - 1101
  • [9] THE ROLE OF ADJUVANT THERAPY AFTER RESECTION OF T1 N1 M0 AND T2 N1 M0 NON-SMALL CELL LUNG-CANCER
    FERGUSON, MK
    LITTLE, AG
    GOLOMB, HM
    HOFFMAN, PC
    DEMEESTER, TR
    BEVERIDGE, R
    SKINNER, DB
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1986, 91 (03): : 344 - 349
  • [10] Cons: should a medically inoperable patient with a T2N0M0 non-small cell lung cancer central in the lung hilus be treated using stereotactic body radiotherapy?
    Nestle, Ursula
    Belderbos, Jose
    TRANSLATIONAL LUNG CANCER RESEARCH, 2015, 4 (05) : 623 - 626